Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AstraZeneca claims new immunosuppressants for asthma, bronchitis, rhinitis, etc.

July 22, 1999

New antiasthmatic agent in the pipeline at Nikken Chemicals

July 22, 1999

Novel series of PDE4 inhibitors from Byk Gulden particularly useful for asthma prophylaxis

July 22, 1999

Genset seeks patents for two genes associated with zileuton-induced hepatotoxicity

July 22, 1999

Zambon presents phthalazines useful for Rx of inflammatory/allergic disorders

July 20, 1999

Xanthines acting as inhibitors of PDE4 and/or TNF claimed by Darwin Discovery

July 19, 1999

Dihydrobenzofuran bronchial therapeutics in development at Byk Gulden

July 16, 1999

BTG acquires technology for cytokine inhibition

July 16, 1999

Superoxide dimutase product may reduce asthma and neurodevelopmental deficits in neonates

July 15, 1999

Yoshitomi describes potent, selective tryptase inhibitors

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026